126 related articles for article (PubMed ID: 15113621)
1. Comparison of the effects of two drying methods on polymorphism of theophylline.
Airaksinen S; Karjalainen M; Räsänen E; Rantanen J; Yliruusi J
Int J Pharm; 2004 May; 276(1-2):129-41. PubMed ID: 15113621
[TBL] [Abstract][Full Text] [Related]
2. Characterization of polymorphic solid-state changes using variable temperature X-ray powder diffraction.
Karjalainen M; Airaksinen S; Rantanen J; Aaltonen J; Yliruusi J
J Pharm Biomed Anal; 2005 Sep; 39(1-2):27-32. PubMed ID: 16085131
[TBL] [Abstract][Full Text] [Related]
3. Phase transformations of erythromycin A dihydrate during pelletisation and drying.
Römer M; Heinämäki J; Miroshnyk I; Sandler N; Rantanen J; Yliruusi J
Eur J Pharm Biopharm; 2007 Aug; 67(1):246-52. PubMed ID: 17270405
[TBL] [Abstract][Full Text] [Related]
4. Stability of polymorphic forms of ranitidine hydrochloride.
Wu V; Rades T; Saville DJ
Pharmazie; 2000 Jul; 55(7):508-12. PubMed ID: 10944778
[TBL] [Abstract][Full Text] [Related]
5. Processing-induced phase transitions of theophylline--implications on the dissolution of theophylline tablets.
Tantry JS; Tank J; Suryanarayanan R
J Pharm Sci; 2007 May; 96(5):1434-44. PubMed ID: 17455350
[TBL] [Abstract][Full Text] [Related]
6. Real-time monitoring of changes of adsorbed and crystalline water contents in tablet formulation powder containing theophylline anhydrate at various temperatures during agitated granulation by near-infrared spectroscopy.
Otsuka M; Kanai Y; Hattori Y
J Pharm Sci; 2014 Sep; 103(9):2924-2936. PubMed ID: 24832393
[TBL] [Abstract][Full Text] [Related]
7. Role of excipients in hydrate formation kinetics of theophylline in wet masses studied by near-infrared spectroscopy.
Jørgensen AC; Airaksinen S; Karjalainen M; Luukkonen P; Rantanen J; Yliruusi J
Eur J Pharm Sci; 2004 Sep; 23(1):99-104. PubMed ID: 15324927
[TBL] [Abstract][Full Text] [Related]
8. Moisture and drug solid-state monitoring during a continuous drying process using empirical and mass balance models.
Fonteyne M; Gildemyn D; Peeters E; Mortier ST; Vercruysse J; Gernaey KV; Vervaet C; Remon JP; Nopens I; De Beer T
Eur J Pharm Biopharm; 2014 Aug; 87(3):616-28. PubMed ID: 24613541
[TBL] [Abstract][Full Text] [Related]
9. Dehydration studies using a novel multichamber microscale fluid bed dryer with in-line near-infrared measurement.
Räsänen E; Rantanen J; Mannermaa JP; Yliruusi J; Vuorela H
J Pharm Sci; 2003 Oct; 92(10):2074-81. PubMed ID: 14502546
[TBL] [Abstract][Full Text] [Related]
10. Pellet manufacturing by extrusion-spheronization using process analytical technology.
Sandler N; Rantanen J; Heinämäki J; Römer M; Marvola M; Yliruusi J
AAPS PharmSciTech; 2005 Sep; 6(2):E174-83. PubMed ID: 16353975
[TBL] [Abstract][Full Text] [Related]
11. Effects of excipients on hydrate formation in wet masses containing theophylline.
Airaksinen S; Luukkonen P; Jørgensen A; Karjalainen M; Rantanen J; Yliruusi J
J Pharm Sci; 2003 Mar; 92(3):516-28. PubMed ID: 12587113
[TBL] [Abstract][Full Text] [Related]
12. On-line monitoring of vacuum drying of theophylline using NIR spectroscopy: solid-state transitions, water content and semi-empirical modeling.
Amira T; Roman P; Fethi Z
Drug Dev Ind Pharm; 2016 Nov; 42(11):1825-32. PubMed ID: 27094058
[TBL] [Abstract][Full Text] [Related]
13. A high throughput platform for understanding the influence of excipients on physical and chemical stability.
Raijada D; Cornett C; Rantanen J
Int J Pharm; 2013 Aug; 453(1):285-92. PubMed ID: 22944300
[TBL] [Abstract][Full Text] [Related]
14. Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures.
Windbergs M; Strachan CJ; Kleinebudde P
J Control Release; 2009 Aug; 137(3):211-6. PubMed ID: 19358867
[TBL] [Abstract][Full Text] [Related]
15. Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.
Kamada K; Yoshimura S; Murata M; Murata H; Nagai H; Ushio H; Terada K
Int J Pharm; 2009 Feb; 368(1-2):103-8. PubMed ID: 19007870
[TBL] [Abstract][Full Text] [Related]
16. Transitiometric analysis of solid II/solid I transition in anhydrous theophylline.
Legendre B; Randzio SL
Int J Pharm; 2007 Oct; 343(1-2):41-7. PubMed ID: 17532155
[TBL] [Abstract][Full Text] [Related]
17. Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulation.
Airaksinen S; Karjalainen M; Kivikero N; Westermarck S; Shevchenko A; Rantanen J; Yliruusi J
AAPS PharmSciTech; 2005 Oct; 6(2):E311-22. PubMed ID: 16353990
[TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of polymorphic impurity by X-ray powder diffractometry in an OROS formulation.
Varasteh M; Deng Z; Hwang H; Kim YJ; Wong GB
Int J Pharm; 2009 Jan; 366(1-2):74-81. PubMed ID: 18840515
[TBL] [Abstract][Full Text] [Related]
19. Drug hydrate systems and dehydration processes studied by terahertz pulsed spectroscopy.
Zeitler JA; Kogermann K; Rantanen J; Rades T; Taday PF; Pepper M; Aaltonen J; Strachan CJ
Int J Pharm; 2007 Apr; 334(1-2):78-84. PubMed ID: 17129691
[TBL] [Abstract][Full Text] [Related]
20. Influence of storage condition on properties of MCC II-based pellets with theophylline-monohydrate.
Krueger C; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2014 Oct; 88(2):483-91. PubMed ID: 24950003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
